Conferences
ASCO GU 2019: POTOMAC Study - Durvalumab and BCG versus BCG Alone in High-risk, BCG-Naïve Non Muscle-Invasive Bladder Cancer
February 19, 2019
ASCO GU 2019: Renal Function Preservation in Kidney Cancer: Current Techniques and Biomarkers
February 19, 2019
ASCO GU 2019: Phase II Study of Ribociclib in Men with Unresectable, Incurable Teratoma with Recent Progression
February 19, 2019
ASCO GU 2019: Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer
February 19, 2019
ASCO GU 2019: Prevention of Symptomatic Skeletal Events with Denosumab: REDUSE Trial
February 19, 2019
ASCO GU 2019: Ramucirumab Exposure-Response Relationship in RANGE: Trial in Advanced Platinum-Refractory Urothelial Carcinoma
February 19, 2019
ASCO GU 2019: Non-Clear Cell Renal Cell Carcinoma: Jumping on the Immunotherapy Bandwagon
February 19, 2019
ASCO GU 2019: Risk Stratification After Resection of Localized Disease: Which Model to Use, and Why?
February 19, 2019
ASCO GU 2019: Pembrolizumab in Muscle-Invasive and Locally Advanced Urothelial Carcinoma - AMBASSADOR versus Observation
February 19, 2019
MDxHealth Announces Presentation of Positive Data for SelectMDx and ConfirmMDx in Prostate Cancer Diagnosis
February 19, 2019
ASCO GU 2019: CB-839, A Glutaminase Inhibitor, in Combination with Cabozantinib in Patients with Clear Cell and Papillary Metastatic Renal Cell Cancer
February 18, 2019
ASCO GU 2019: Informing the Decision Using Clinical Trial Evidence - Localized Kidney Cancer
February 18, 2019